NIPH Clinical Trials Search

UMIN ID: C000000249

Registered date:01/09/2006

A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedMalignant gastrointestinal obstruction
Date of first enrollment2003/07/01
Target sample size33
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Under local anesthesia and fluoroscopy or ultrasonic guidance, a percutaneous route to cervical esophagus is made by direct puncture to the intra-esophageal balloon inserted via nasal or oral route, and then, a drainage tube is placed from the neck surface to the stomach using this route.


Primary OutcomeImprovement of subjective symptoms compared to previous nasal tubing.
Secondary OutcomeAdverse events and feasibility of procedure

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Tracheostomy. 2) Intestinal obstruction due to the lesions between transverse colon and rectum. 3) Pregnancy. 4) Local therapy for neck region

Related Information


public contact
Name Yasuaki Arai
Address 5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan Japan
Telephone 0335422511
Affiliation JIVROSG, Coordinating Office Division of Diagnostic Radiology, National Cancer Center Hospital
scientific contact
Name Takeshi Aramaki
Address 1007, Shimonagakubo, Nagaizumi-cho, Shuntoh-gun, Shizuoka 411-8777, Japan Japan
Affiliation Shizuoka Cancer Center Department of Imaging Diagnosis